Featured Articles

  1. Accelerated Development Of Self-Amplifying mRNA (saRNA) Vaccines Using Microfluidics 4/14/2022

    We showcased the utility of microfluidics to enable low shear, rapid screening of preclinical candidates and the swift advancement to GMP-enabling studies.

  2. How Tools And Technologies Bring Advanced Therapies To Market 3/2/2022

    Gain insight into industry trends and the tools to support the development of RNA vaccines and therapeutics.

  3. Changing The Status Quo Of Vaccine Production 3/2/2022

    Learn how the mRNA technology behind COVID-19 vaccines is poised to disrupt the status quo to improve global vaccine manufacturing capabilities.

  4. Translation Of RNA Medicines From Design To Clinic 3/2/2022

    Understand the advantages and challenges of lipid-based delivery systems for successful translation of RNA into clinical development.

  5. Accelerating The Development And Scale-Up Of mRNA Vaccines 3/2/2022

    Learn how downstream considerations can make the difference between success and failure on the path towards the commercialization of mRNA vaccines.

  6. Genomic Medicine And The Tools To Realize Its Potential 1/12/2022

    New technologies and collaborations driving the democratization of RNA therapeutics are creating an explosion of opportunity for companies pursuing the development of these transformative medicines.

  7. Automated Bag Thawing System For CAR-T Cell Therapy Manufacturing 1/11/2022

    The performance of the VIA Thaw CB1000 is compared to thawing in a water bath. The VIA Thaw™ dry thawing system shows comparable performance to a water bath with less handling.

  8. Scalable AAV Purification Process For Gene Therapy 11/22/2021

    Processes to produce AAV for gene therapies are in place, but there’s room to optimize purification to achieve high overall yields and efficiently remove empty capsids and other impurities.

  9. Process Development For AAV Vector Production In Suspension Cells 11/19/2021

    Review experiments for the adaptation of the HEK293 suspension cell line for transient transfection and scalable adeno-associated virus (AAV) production.

  10. Key Insights Into Overcoming mRNA Process Challenges 9/8/2021

    Realizing the potential of mRNA requires focus on key areas and strategies that could help alleviate the bottlenecks in this growing market segment.